Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Overview

authors

Weir, Barbara A

Heynck, Stefanie

Rabinovsky, Rosalia

Weiss, Jonathan

Fischer, Florian

Frommolt, Peter

Michel, Kathrin

Peyton, Michael

Garraway, Levi A

Pao, William
Meyerson, Matthew
Thomas, Roman K

publication date

March 3, 2025

published in

Cancer research Journal

Identity

Scopus Document Identifier

85219745124

Digital Object Identifier (DOI)

10.1158/0008-5472.CAN-24-5044

PubMed ID

40025966

Additional Document Info

volume

85

issue

5